Rating Change
Baird analysts reiterated a Neutral rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on July 22, 2026.
reiterateNASDAQ:SBRA
Baird Reiterates Neutral Rating on Sabra Health Care REIT, Inc. (SBRA)
Rating Change Baird analysts reiterated a Neutral rating on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) on July 22, 2026. Market Context Sabra Health Care REIT, Inc.
Market Context
Sabra Health Care REIT, Inc. operates in the Real Estate sector. The stock currently trades at $21.98 with a market capitalization of $4.5B.
Analyst coverage from Baird provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sabra Health Care REIT, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Sabra Health Care REIT, Inc.
Among the 10 most recent ratings: 4 Buy, 5 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 22, 2026 | Citizens | Market Outperform | N/A |
| Jul 22, 2026 | Truist Securities | Buy | N/A |
| Jul 22, 2026 | Baird | Neutral | N/A |
| Jul 08, 2026 | Truist Securities | Buy | N/A |
| Jul 08, 2026 | UBS | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View SBRA Stock Page
Frequently Asked Questions
What does a Neutral rating mean for SBRA?
A Neutral rating from Baird reflects the analyst's outlook on Sabra Health Care REIT, Inc. (NASDAQ:SBRA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SBRA forecast page.